Advertisement

Latest News

From Eosinophils to Image Biomarkers: The Evolving Science of Biologic Selection in Asthma and COPD

1 hour ago

What Changes Is AI Making in Dermatology? With Vinod Nambudiri, MD, MBA, MPH

1 hour ago

At the 2026 AAD Annual Meeting, Nambudiri spoke on various points, including how emerging AI tools may help reduce administrative burden in dermatology.

Treatment Selection in Psoriasis

2 hours ago

New psoriasis data show durable, rapid skin clearance with modern biologics, spotlighting bimekizumab’s four-year remission and patient-tailored selection.

FDA Expands Teplizumab Approval to Children 1 Year & Older to Delay Type 1 Diabetes Onset

2 hours ago

Teplizumab is now approved to treat stage 2 type 1 diabetes in kids 1 year and older.

Understanding Biologic Therapies in Psoriasis

3 hours ago

Explore how psoriasis biologics differ—TNF vs IL‑23/IL‑17—why classes matter, and what targeted therapy means for safety and results.

Advertisement
Advertisement